Ikena Oncology

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ikena Oncology and other ETFs, options, and stocks.

About IKNA

Ikena Oncology, Inc. is a clinical stage biotechnology company, which engages in the development of patient directed and biomarker driven therapies for cancer patients. Its product pipeline includes IK-930, RAS Signaling, IK-175, IK-412, and IK-007.

CEO

Mark Manfredi

CEOMark Manfredi

Employees

Employees43

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2016

Founded2016

Employees

Employees43

IKNA Key Statistics

Market cap

64.18M

Market cap64.18M

Price-Earnings ratio

-0.77

Price-Earnings ratio-0.77

Dividend yield

—

Dividend yield—

Average volume

236.43K

Average volume236.43K

High today

$1.36

High today$1.36

Low today

$1.25

Low today$1.25

Open price

$1.25

Open price$1.25

Volume

333.93K

Volume333.93K

52 Week high

$7.64

52 Week high$7.64

52 Week low

$1.02

52 Week low$1.02

Ikena Oncology

Why Robinhood?

Ikena Oncology, Inc. is a clinical stage biotechnology company, which engages in the development of patient directed and biomarker driven therapies for cancer patients. Its product pipeline includes IK-930, RAS Signaling, IK-175, IK-412, and IK-007. Show more

IKNA Key Statistics

Ikena Oncology, Inc. is a clinical stage biotechnology company, which engages in the development of patient directed and biomarker driven therapies for cancer patients. Its product pipeline includes IK-930, RAS Signaling, IK-175, IK-412, and IK-007.